For a 10 mg vial, this yields a concentration of 5 mg/mL (5,000 mcg/mL)
There was no difference between groups in the proportion receiving thyroid hormone replacement therapy and/or use of analgesics
Vague claims about which drug works better help nobody
Lecanemab and donanemab are approved for use in individuals with MCI or mild dementia due to Alzheimer's (clinical stages 3 and 4 on the Alzheimer's disease continuum) and confirmation of elevated levels of betaamyloid in the brain
Sader HS, Fedler KA, Rennie RP, Stevens S, Jones RN: Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity
Note: Vials shown in images are for demonstration purposes only and are not included